TITLE

Dual effect of the SR proteins ASF/SF2, SC35 and 9G8 on HIV-1 RNA splicing and virion production

AUTHOR(S)

Jacquenet, Sandrine; Decimo, Didier; Muriaux, Delphine; Darlix, Jean-Luc

PUB. DATE

January 2005

SOURCE

Retrovirology;2005, Vol. 2, p33

SOURCE TYPE

Academic Journal

DOC. TYPE

Article

ABSTRACT

In HIV-1 infected cells transcription of the integrated provirus generates the single full length 9 kb viral RNA, a major fraction of which is spliced to produce the single-spliced 4 kb RNAs and the multiple-spliced 2 kb RNAs. These spliced RNAs are the messengers for the Env glycoproteins and the viral regulatory factors. The cellular SR and hnRNP proteins were shown in vitro to control alternative splicing by binding cis-regulatory elements on the viral RNA. To better understand in vivo the role of the SR proteins on HIV-1 genomic RNA splicing and virion production, we used a human cell line expressing high levels of complete HIV-1 and either one of the ASF/SF2, SC35, and 9G8 SR proteins. Results show that over-expressing SR proteins caused a large reduction of genomic RNA and that each SR protein modified the viral 9 kb RNA splicing pattern in a specific mode. In fact, ASF/SF2 increased the level of Vpr RNA while SC35 and 9G8 caused a large increase in Tat RNA. As expected, overexpressing SR proteins caused a strong reduction of total Gag made. However, we observed by immuno-confocal microscopy an accumulation of Gag at the plasma membrane and in intracellular compartments while there is a dramatic reduction of Env protein made in most cells. Due to the negative impact of the SR proteins on the levels of genomic RNA and HIV-1 structural proteins much less virions were produced which retained part of their infectivity. In conclusion, SR proteins can down-regulate the late steps of HIV-1 replication.

ACCESSION #

30739543

Tags: GENETICS;  HIV (Viruses);  HIV infections;  RNA;  NUCLEIC acids;  BIOMOLECULES

 

Related Articles

• HIV-1 Subtype as a Determinant of Disease Progression. Kuritzkes, Daniel R. // Journal of Infectious Diseases;3/1/2008, Vol. 197 Issue 5, p637 

  The article presents a report which determines HIV-1 subtype as a determinant of disease progression. It is posed that various factors, including plasma HIV-1 RNA level, degree of immune activation, age, CD4 cell count, and host genetics, add to determining the rate of progression of disease in...

• Patterns of HIV-1 Protein Interaction Identify Perturbed Host-Cellular Subsystems. MacPherson, Jamie I.; Dickerson, Jonathan E.; Pinney, John W.; Robertson, David L. // PLoS Computational Biology;Jul2010, Vol. 6 Issue 7, p1 

  Human immunodeficiency virus type 1 (HIV-1) exploits a diverse array of host cell functions in order to replicate. This is mediated through a network of virus-host interactions. A variety of recent studies have catalogued this information. In particular the HIV-1, Human Protein Interaction...

• Screening for Acute HIV Infection: Lessons Learned. Stekler, Joanne; Maenza, Janine; Stevens, Claire E.; Swenson, Paul D.; Coombs, Robert W.; Wood, Robert W.; Campbell, Mary S.; Nickle, David C.; Collier, Ann C.; Golden, Matthew R. // Clinical Infectious Diseases;2/1/2007, Vol. 44 Issue 3, p459 

  Human immunodeficiency virus (HIV) nucleic acid testing is increasingly being used by researchers and public health screening programs to identify highly infectious, HIV antibody-negative individuals with acute HIV infection. We present cases to illustrate unusual instances of acute HIV...

• Optimizing de novo transcriptome assembly from short-read RNA-Seq data: a comparative study. Qiong-Yi Zhao; Yi Wang; Yi-Meng Kong; Da Luo; Xuan Li; Pei Hao // BMC Bioinformatics;2011 Supplement 14, Vol. 12 Issue Suppl 14, p1 

  Background: With the fast advances in nextgen sequencing technology, high-throughput RNA sequencing has emerged as a powerful and cost-effective way for transcriptome study. De novo assembly of transcripts provides an important solution to transcriptome analysis for organisms with no reference...

• Analysis of 16S rRNA environmental sequences using MEGAN. Mitra, Suparna; St�rk, Mario; Huson, Daniel H. // BMC Genomics;2011 Supplement 3, Vol. 12 Issue Suppl 3, p1 

  Background: Metagenomics is a rapidly growing field of research aimed at studying assemblages of uncultured organisms using various sequencing technologies, with the hope of understanding the true diversity of microbes, their functions, cooperation and evolution. There are two main approaches to...

• Applicability of RNA standards for evaluating RT-qPCR assays and platforms. Devonshire, Alison S.; Elaswarapu, Ramnath; Foy, Carole A. // BMC Genomics;2011, Vol. 12 Issue 1, p118 

  The availability of diverse RT-qPCR assay formats and technologies hinder comparability of data between platforms. Reference standards to facilitate platform evaluation and comparability are needed. We have explored using universal RNA standards for comparing the performance of a novel qPCR...

• A real-time view of the TAR:Tat:P-TEFb complex at HIV-1 transcription sites. Molle, Doroth�e; Maiuri, Paolo; Boireau, St�phanie; Bertrand, Edouard; Knezevich, Anna; Marcello, Alessandro; Basyuk, Eugenia // Retrovirology;2007, Vol. 4, p36 

  HIV-1 transcription is tightly regulated: silent in long-term latency and highly active in acutely-infected cells. Transcription is activated by the viral protein Tat, which recruits the elongation factor P-TEFb by binding the TAR sequence present in nascent HIV-1 RNAs. In this study, we...

• HIV restriction in quiescent CD4+ T cells. Zack, Jerome A.; Kim, Sohn G.; Vatakis, Dimitrios N. // Retrovirology;2013, Vol. 10 Issue 1, Special section p1 

  The restriction of the Human Immunodeficiency Virus (HIV) infection in quiescent CD4+ T cells has been an area of active investigation. Early studies have suggested that this T cell subset is refractory to infection by the virus. Subsequently it was demonstrated that quiescent cells could be...

• Broad-spectrum antiviral strategy. Hare, Peter // Nature Biotechnology;Oct2011, Vol. 29 Issue 10, p885 

  The article discusses research about the potential of double-stranded RNA-activated caspase oligomerizers (DRACOs) as a broad-spectrum antiviral strategy.

Read the Article